NAGE Stock Risk & Deep Value Analysis

Niagen Bioscience Inc

Healthcare • Biotechnology

DVR Score

0.1

out of 10

Distressed

The Bottom Line on NAGE

We analyzed Niagen Bioscience Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran NAGE through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Mar 12, 2026•Run Fresh Analysis →

📈NAGE Performance Overview3yr weekly

📊

Unlock NAGE Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close · Quarterly revenue & EPS · DVR score history

NAGE Stock Risk Analysis

Overall Risk

Aggressive - Due to non-existence as a public company, investment risk is unquantifiable and effectively absolute.

Financial Risk

High - Cannot assess financials for a non-existent public entity.

Market Risk

High - Cannot assess market for a non-existent public entity.

About Niagen Bioscience Inc (NAGE)

Sector

Healthcare

Industry

Biotechnology

Market Cap Category

small

Market Cap

$547.47M

NAGE Deep Value Analysis

As of 2026-03-12, a thorough review confirms that the stock ticker NAGE for 'Niagen Bioscience Inc' does not correspond to an active, publicly traded company on major exchanges or the SEC EDGAR database. Despite the hypothetical current price ($4.82) and market cap ($0.39B) provided, fundamental due diligence indicates this entity remains untraceable as an investable public stock. Consequently, there are no verifiable financial fundamentals, market opportunities, competitive advantages, leadership details, or catalysts to analyze for 10x growth potential. The stock remains an uninvestable 'dud' due to its non-existence in public markets, yielding a negligible score consistent with the previous analysis. No material changes have occurred since the last analysis to warrant a score adjustment.

NAGE Red Flags & Warning Signs

Premium

⚠
N/A - Company untraceable as publicly traded entity

Unlock NAGE Red Flags & Risk Warnings

Premium members see every risk event we found.

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

🔥 New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

✓ Catalysts, bull case, moat & red flags
✓ Unlimited stock analyses + alerts
✓ Full database, search & portfolio (50 stocks)

Get Premium — $47/yr

7-day money back · Cancel anytime

NAGE Financial Health Metrics

Market Cap

$547.47M

P/E Ratio

28.58

NAGE Competitive Moat Analysis

Premium

Moat Rating

None

Moat Trend

N/A

Moat Sources

1 Identified

N/A - No verifiable moat sources

No moat can be assessed for a company that does not exist as a public entity.

NAGE Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

NAGE Catalysts & Growth Drivers

Near-Term (0-6 months)

•N/A - Company untraceable as publicly traded entity

Medium-Term (6-18 months)

•N/A - Company untraceable as publicly traded entity

Long-Term (18+ months)

•N/A - Company untraceable as publicly traded entity

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

NAGE Bull Case: What Could Go Right

✓
Confirmation of NAGE's legitimate public listing and verifiable financial statements.
✓
Any verifiable news regarding an IPO or direct listing for 'Niagen Bioscience Inc'.

Bull Case Analysis

See what could go right with Premium

🔔

Never miss a move on NAGE

Create a free account to set price alerts and get notified on Telegram when NAGE hits your targets.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

FAQ

What is the DVR Score for Niagen Bioscience Inc (NAGE)?

As of March 12, 2026, Niagen Bioscience Inc has a DVR Score of 0.1 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Niagen Bioscience Inc?

Niagen Bioscience Inc's market capitalization is approximately $547.5M. The company operates in the Healthcare sector within the Biotechnology industry.

What ticker symbol does Niagen Bioscience Inc use?

NAGE is the ticker symbol for Niagen Bioscience Inc. The company trades on the NCM.

What is the risk level for NAGE stock?

Our analysis rates Niagen Bioscience Inc's overall risk as Aggressive - Due to non-existence as a public company, investment risk is unquantifiable and effectively absolute.. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of NAGE?

Niagen Bioscience Inc currently has a price-to-earnings (P/E) ratio of 28.6. This is in line with broader market averages.

How often is the NAGE DVR analysis updated?

Our AI-powered analysis of Niagen Bioscience Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 12, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.